Relation between indices of end-organ damage and mean platelet volume in hypertensive patients

Serkan Bulur1, Halil Ibrahim Önder, Yusuf Aslantas

  • 1Duzce Medical School, Department of Cardiology, Düzce University, Konuralp, Düzce, Turkey. drserkanbulur@yahoo.com

Insights

Mean platelet volume (MPV) did not correlate with markers of end-organ damage in hypertension patients. This study found no association between MPV levels and left-ventricular mass index, albuminuria, or retinopathy.

Area of Science:

  • Cardiology
  • Nephrology
  • Ophthalmology

Background:

  • Mean platelet volume (MPV) is an independent risk factor for hypertension.
  • Hypertensive end-organ damage significantly impacts patient prognosis.
  • Investigating MPV's role in subclinical damage is crucial for understanding hypertension progression.

Purpose of the Study:

  • To examine the association between mean platelet volume (MPV) and subclinical end-organ damage in hypertensive individuals.
  • To determine if MPV levels correlate with left-ventricular mass index (LVMI), albuminuria, or retinopathy in hypertension.

Main Methods:

  • A cohort of 116 hypertensive patients (mean age 53 ± 11 years) was analyzed.
  • MPV levels were measured and compared against LVMI, urinary albumin-to-creatinine ratio, and retinopathy grading.
  • Statistical analysis, including correlation coefficients (r) and P-values, was performed.

Main Results:

  • No significant correlation was found between MPV and left-ventricular mass index (r = 0.145; P = 0.14).
  • MPV showed no association with albuminuria (r = 0.009; P = 0.93).
  • Similar MPV levels were observed in patients with grade I and grade II retinopathy (P = 0.28).

Conclusions:

  • This study found no correlation between mean platelet volume (MPV) and key markers of end-organ damage in hypertensive patients.
  • MPV does not appear to be a reliable indicator of subclinical organ damage in this hypertensive cohort.
  • Further research may be needed to explore other potential biomarkers or mechanisms in hypertensive end-organ damage.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...